Akorn opening: Dr. John N. Kapoor, chief executive officer of Akorn, has resigned but will continue as chairman of the board. The company said it has no immediate plans to fill his post.
From waste to wonder: Transformational advances in scleral allograft technology
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
Iantrek announces 1-year clinical results of its bio-interventional technology for uveoscleral outflow enhancement in open-angle glaucoma patients
Advancing the optimal diagnosis & treatment of thyroid eye disease
ANI Pharmaceuticals completes acquisition of Alimera Sciences
Expanding the range of vision with monofocal IOLs